Loading...
Indian Pharmaceutical Exporter · #9 for Formoterol · $154.5K export value · DGFT Verified
Cadila Healthcare Ltd is the #9 Indian exporter of Formoterol with $154.5K in export value and 14 verified shipments. Cadila Healthcare Ltd holds a 0.3% market share in Formoterol exports across 4 countries.
| $5.8K |
| 2 |
| 2.2% |
Cadila Healthcare Ltd exports Formoterol to 5 countries. The largest destination is SRI LANKA accounting for 70.1% of Cadila Healthcare Ltd's Formoterol shipments, followed by VIETNAM (19.0%) and KENYA (5.0%). These destinations reflect Cadila Healthcare Ltd's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| SUNSHINE HEALTHCARE LANKA LIMITED | SRI LANKA | $184.3K | 20 |
| HAPHARCOJ S CBRANCH | VIETNAM | $50.0K | 1 |
| GALAXY PHARMACEUTICAL LIMITED | KENYA | $13.1K | 1 |
| M PHARMA CO LTD | SUDAN | $9.6K | 1 |
| FTM MAURITIUS LTD | MAURITIUS | $5.8K | 2 |
Cadila Healthcare Ltd supplies Formoterol to 5 buyers globally. The largest buyer is SUNSHINE HEALTHCARE LANKA LIMITED (SRI LANKA), followed by HAPHARCOJ S CBRANCH (VIETNAM) and GALAXY PHARMACEUTICAL LIMITED (KENYA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $39.0M worth of Formoterol through 4,917 shipments from 153 suppliers to 81 countries, serving 320 buyers globally. Cadila Healthcare Ltd contributes $154.5K to this total, accounting for 0.3% of India's Formoterol exports. Cadila Healthcare Ltd ships Formoterol to 5 countries through 5 buyers.
Cadila Healthcare Ltd's average Formoterol shipment value is $11.0K per consignment, based on 14 shipments totaling $154.5K. The largest destination is SRI LANKA (70.1% of Cadila Healthcare Ltd's Formoterol exports).
Cadila Healthcare Ltd ranks #9 among 153 Indian Formoterol exporters with a 0.3% market share. The top 3 exporters are CIPLA LIMITED ($25.3M), MANKIND PHARMA LIMITED ($8.6M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($1.8M). Cadila Healthcare Ltd processed 14 shipments to 4 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FORMONIDE 400 MDI 1'S- HFAFORMOTEROL FUMARATE & BUDESONIDE INHALATION1 X 1 UNIT | $80.5K | 7 |
| FORMONIDE 200 INHALERBUDESONIDE & FORMOTEROL FUMARATE INHALER1X120MDI | $50.0K | 1 |
| FORMONIDE 400 MDI 1'S- HFAFORMOTEROL FU | $39.6K | 2 |
| FORMONIDE 200 RESPICAPSBUDESONIDE AND FORMOTEROL FUMARATE RESPICAP3X10 | $22.2K | 6 |
| FORMONIDE 400 MDI 1'S- HFA FORMOTEROL F | $22.1K | 1 |
| FORMONIDE 200 MDI 1'S- HFAFORMOTEROL FUMARATE & BUDESONIDE INHALATION1 X 1 UNIT | $13.5K | 2 |
| FORMONIDE 400 INHALER BUDESONIDE & FORMOTEROL FUMARATE INHALER 1X120MDI | $13.1K | 1 |
| FORMONIDE200HFA INHCFC FREE120MDIBUDESONIDE & FORMOTEROL FUMARATE INHALER1X 120 MD | $9.6K | 1 |
| FORMONIDE 200 MDI 1'S- HFAFORMOTEROL FU | $3.2K | 1 |
| FORMONIDE 400 RESPICAPS BUDESONIDE AND FORMOTEROL FUMARATE RESPICAP B.No AHZ1013A MANUFACTURING .DT. 08/2023 EXP.DT. 01/2025 | $3.2K | 1 |
Cadila Healthcare Ltd exports 12 distinct Formoterol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FORMONIDE 400 MDI 1'S- HFAFORMOTEROL FUMARATE & BUDESONIDE I with 7 shipments worth $80.5K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | MACLEODS PHARMACEUTICALS LTD | $239.9K | 7 | 2 | $34.3K |
| 7 | MEDISPRAY LABORATORIES PVT LTD | $200.0K | 4 | 1 | $50.0K |
| 9 | CADILA HEALTHCARE LTD ★ | $154.5K | 14 | 4 | $11.0K |
| 10 | CADILA HEALTHCARE LIMITED | $145.5K | 11 | 2 | $13.2K |
| 11 | SAVIOUR INTERNATIONAL | $117.2K | 12 | 2 | $9.8K |
Cadila Healthcare Ltd ranks #9 among 153 Indian Formoterol exporters. Average shipment value of $11.0K compared to the market average of $255.0K. The closest competitors by value are MACLEODS PHARMACEUTICALS LTD and MEDISPRAY LABORATORIES PVT LTD.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 898 | 18.3% |
| DELHI AIR | 817 | 16.6% |
| DELHI AIR CARGO ACC (INDEL4) | 758 | 15.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 660 | 13.4% |
| NHAVA SHEVA SEA (INNSA1) | 322 | 6.5% |
| Delhi Air | 256 | 5.2% |
| Bombay Air | 139 | 2.8% |
| Bombay Air Cargo | 99 | 2.0% |
Latest developments and market context
Detailed market intelligence for Formoterol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 81+ countries, 320+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Cadila Healthcare Ltd's Formoterol exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Cadila Healthcare Ltd
Company Profile
0 products · $0 total trade · 0 categories
Access shipment-level records, pricing trends, and buyer contacts for Cadila Healthcare Ltd.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Formoterol. For current shipment-level data, contact TransData Nexus.